Montefiore Cancer Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Sumitomo Pharma America, Inc.1 trial
• University of Michigan Rogel Cancer Center1 trial

Running trials

• Recruiting

  A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  NCT04176198· Phase 1/2· Sumitomo Pharma America, Inc.· Source

  Contact: Olivia Orellano

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents

  NCT03242915· Phase 2· University of Michigan Rogel Cancer Center· Source